" alt="Blog de Enfermedades Digestivas y Metabólicas" />
Programar visita

Blog de Enfermedades Digestivas y Metabólicas

@barnaclinic

29 October, 2026

Type 1 diabetes, an autoimmune disease: what happens in the body and how it can be slowed down


Autoimmune type 1 diabetes occurs when the body’s own immune system attacks the cells in the pancreas that produce insulin. This process can begin months or even years before the first symptoms appear. And, for the first time, there are biological therapies that can slow it down in some people. To understand what happens in the body and what these treatments can offer today, we spoke to Dr. Jesús Blanco, endocrinologist specialising in diabetes at barnaclínic+.

Why is type 1 diabetes an autoimmune disease?

In type 1 diabetes, part of the immune system attacks the beta cells of the pancreas, which are responsible for producing insulin. Over time, the body gradually loses its ability to make it.

The main players in this attack are a type of white blood cell: T lymphocytes. Dr. Blanco suggests picturing them as small spheres with a kind of antennae on their surface, which they use to communicate with other cells. One particular family of these antennae, called CD3, is essential for them to work.

Until now, medicine had no tools to intervene in this process. Treatment consisted of replacing the missing insulin, using insulin pens, multiple daily injections or automated insulin delivery systems. As the specialist puts it:

Dr. Jesús Blanco - Endocrinologist specialising in diabetes at barnaclínic+“The whole history of type 1 diabetes treatment has revolved around the use of insulin in different forms.”

Dr. Jesús Blanco
Endocrinologist specialising in diabetes at barnaclínic+

The stages of autoimmune type 1 diabetes

The autoimmune process progresses in phases. Today, three stages of type 1 diabetes are recognised:

In stages 1 and 2, the person has no symptoms. That is why this phase of the disease goes unnoticed unless it is actively looked for. If you want to know how type 1 diabetes differs from other forms of the disease, we explain it in our article on the types of diabetes.

Autoantibodies: the warning sign before symptoms

Asymptomatic forms of type 1 diabetes are diagnosed with a blood test that detects the presence or absence of the antibodies associated with the disease. Glucose testing then shows which stage the person is in.

This test is intended for people without symptoms, especially relatives of people with type 1 diabetes. In children, according to the specialist, it could also be extended to the general population.

Dr. Jesús Blanco - Endocrinologist specialising in diabetes at barnaclínic+“Screening people who already have symptoms makes no sense, because what we need to do is diagnose diabetes. We need to screen people without symptoms.”

Dr. Jesús Blanco
Endocrinologist specialising in diabetes at barnaclínic+

At barnaclínic+ you can take the test as part of our type 1 diabetes screening programme.

In this video, Dr. Blanco explains how the immune system acts in type 1 diabetes and what the new biological therapies can offer:

 

Ver esta publicación en Instagram

 

Una publicación compartida de barnaclínic+ (@barnaclinic)

Can the autoimmune attack be slowed down? Biological therapies

The big change in recent years is that treatment no longer addresses only the consequence (the lack of insulin), but also the cause: the attack by the immune system. The first biological therapies approved for type 1 diabetes block the CD3 molecule on T lymphocytes, thereby changing the way they work.

Dr. Blanco explains it with an everyday comparison:

Dr. Jesús Blanco - Endocrinologist specialising in diabetes at barnaclínic+“To use an analogy, it manages to reset the immune system, as if we pressed the power button when our computer has a problem and we manage to restart it.”

Dr. Jesús Blanco
Endocrinologist specialising in diabetes at barnaclínic+

With this “restart”, the white blood cells change the way they behave and the attack on the insulin-producing cells slows down. As a result, diabetes appears later than it would have done if the process had followed its natural course.

The first biological therapy with this mechanism approved in Europe is teplizumab. We explain how it is given, who it is indicated for and what results it has shown in our article on the new treatment with teplizumab.

YOU MAY ALSO BE INTERESTED IN…

Can type 1 diabetes be cured with stem cells?

Why there is only room to act in the early stages

Today, these therapies are only approved for stage 2 type 1 diabetes: they cannot be used in stage 1 or in stage 3. The reason is that slowing the attack only makes sense while the pancreas can still produce insulin.

Dr. Jesús Blanco - Endocrinologist specialising in diabetes at barnaclínic+“In cases where diabetes is already established, they will not have much room for manoeuvre.”

Dr. Jesús Blanco
Endocrinologist specialising in diabetes at barnaclínic+

That is why, according to the specialist, the challenge is to identify people in stage 2, who do not yet have symptoms and still preserve their own insulin secretion. In them, there is room to slow the process down and maintain that production for longer.

What to expect: slowing down, not curing

Dr. Blanco is keen to give a realistic message about biological therapies in type 1 diabetes:

Dr. Jesús Blanco - Endocrinologist specialising in diabetes at barnaclínic+“For now, no therapy manages, nor do we expect any to manage, to cure or completely reverse the risk of developing type 1 diabetes.”

Dr. Jesús Blanco
Endocrinologist specialising in diabetes at barnaclínic+

What clinical trials do show is that the first approved therapy slows down the natural course of the autoimmune process. Its effectiveness is measured by comparing two groups of people, one receiving the drug and one not, and calculating the average difference.

This has an important consequence: for any individual, it is impossible to know how long diabetes has been delayed, because we will never know how long it would have taken to appear without treatment. What is known is the average from the studies, which the specialist puts at around a two-year delay, or twice the time until type 1 diabetes appears.

Immunotherapy in diabetes: what lies ahead

For Dr. Blanco, the paradigm shift is clear. For the first time, it is possible to modify the course of a disease that until now could only be treated once it had already appeared:

Dr. Jesús Blanco - Endocrinologist specialising in diabetes at barnaclínic+“That natural history which begins with the immune system attacking the insulin-producing cell, and which we used to overlook because we had no tools to change it.”

Dr. Jesús Blanco
Endocrinologist specialising in diabetes at barnaclínic+

This is not a definitive treatment. But the specialist expects new biological therapies to be added to this treatment option in the coming years, and immunotherapy to play a bigger role in managing type 1 diabetes in its earliest stages.

Early detection and specialist follow-up

At barnaclínic+ we support people at risk of type 1 diabetes from screening through to the assessment of new treatment options, with personalised follow-up by our specialist diabetes team.

DO YOU HAVE A RELATIVE WITH TYPE 1 DIABETES AND WANT TO KNOW YOUR RISK?

Type 1 diabetes screening can detect the disease’s autoantibodies before any symptoms appear.

BOOK AN APPOINTMENT REQUEST A VIDEO CONSULTATION

Leave a reply

I've read and accept the Privacy policy and legal notice
If you want to be informed about our products or services, please mark this box